SAHPRA eCTD Submission Updates
SAHPRA eCTD Portal Launch:
Beginning October 1, 2024, SAHPRA mandates all applications to be submitted via its eCTD Portal. Through this portal, applicants can register, upload content, and manage submission sequences. Detailed instructions are provided in the SAHPRA eCTD Portal Process Guide.
Since June 2016, Health Canada has been providing the Validation Reports only for regulatory transactions that failed validation.
Sponsors are expected to validate their eCTD regulatory transactions and correct any warning(s) and error(s) before sending them to Health Canada.
- On 01 January 2019 the new Swiss Module 1 Specification for eCTD v1.4 is implemented.
- Both versions (v1.3 and v1.4) will be valid for a half-year period from 01 January 2019 to 30 June 2019.
- As from 01 July 2019 the Swiss Module 1 Specification for eCTD v1.4 must be used for all eCTD submissions.
- Note, due to minor errors in the eCTD M1 Specification and the corresponding eCTD Validation Criteria SWISSmedic updated both the guidelines but the version number 1.4 will be retained.
FDA has updated the guideline for Specifications for eCTD Validation Criteria (V3.8). In this version FDA updated;
- Descriptions of the eCTD Validation Criteria of Error Codes 1734, 1735, and 1736 which support the Study Data Technical Conformance Guide
These Validation rules build on the information provided in Preparation of Regulatory Activities in “Non-eCTD Electronic-Only” format guideline.
The revised rules assist stakeholders in the preparation of regulatory transactions in Non-eCTD format.